Introducing our official newsletter
At REPO4EU we are starting the new year in style – and what better way to do that than with the launch of our official quarterly newsletter?
Ever since REPO4EU kicked-off, we have been setting the stage for what we believe will be the future – mechanism-based drug repurposing. Read on to discover the main highlights from our work these past 5 months as presented by our coordinator, Prof. Harald Schmidt. In this first issue you’ll find insights from our experts on ethics and AI, the project’s ongoing clinical trials and our contributions to the regulatory and legal landscape surrounding drug repurposing.
We’re also delighted to share a sneak peek on upcoming dissemination activities with the community – stay tuned for updates on REPO4EU’s open publishing portal and our national events to showcase the project in Spain, Germany, Austria and Sweden!
Sounds interesting? Click here to check out the full newsletter and make sure to subscribe!
Photo by Luca Onniboni on Unsplash
Check out our video compilation for RExPO22
Welcome to the revolution!
120+ attendees, 40+ speakers, 11 posters in show and 42 publications…
RExPO22 wrapped up in September and we’re already looking forward to the next one. In the meantime, check out the official video compilation below to revisit the first international conference on drug repurposing!
About RExPO22
RExPO22, the 1st edition of our international series of conferences dedicated to Systems Medicine, Artificial Intelligence and Drug Repurposing, took place in Munich on 2-3 September 2022
Revisit the conference
Curious to learn more? Watch our video compilation for RExPO23
REPO4EU begins its journey to push the boundaries of drug repurposing
The first step in the journey from imprecise drug therapy to precision medicine – REPO4EU’s Euro/Global Platform for Drug Repurposing
The consortium of REPO4EU (Precision drug REPurpOsing For EUrope and the world) is pleased to announce the launch of an ambitious joint initiative selected and granted almost €23M by the European Commission as part of the Horizon Europe Programme.
REPO4EU’s ultimate goal is to build and grow an industry-level European online platform for validated precision drug repurposing with a global reach. This platform will operate as the go-to data hub for key information, training resources, matchmaking and cooperation in drug repurposing.
The platform will provide extensive expertise throughout the whole value chain in drug repurposing: from freedom-to-operate analysis to intellectual property protection and business development, health technology assessment, ethics and data governance considerations.
During the next 7 years, 28 partners from 10 countries (The Netherlands, Germany, Austria, Spain, Sweden, Romania, Belgium, Portugal, Switzerland and the United States) will join forces to make REPO4EU a reality and create a unique platform for drug repurposing, pooling stakeholders and expertise at a global stage to create a “made in Europe”, fully-fledged infrastructure for drug repurposing.
Sounds interesting?
You can check out our first joint press release in the link below
Our first press release is out!
Many exciting things are on the horizon for this September that we would like to share with everyone in the drug repurposing community!
REPO4EU - the Euro-Global platform for Mechanism-based Drug Repurposing is officially kicking off next month and with it also comes to life RExPO22 - the first international conference on drug repurposing.
You can read all about it in our first joint press release!
Photo by Utsav Srestha on Unsplash
A new piece on Alzheimer from our colleagues at STALICLA
Our colleague Emre Guney from STALICLA (a member of REPO4EU) is one of the co-authors of “A needle for Alzheimer’s in a haystack of claims data“.
In the era of big data, looking for insights in large datasets has become the norm — and health data are no exception. Combining systems-biology-driven, endophenotype-based analysis of drug targets with large-scale medical claims data points to sildenafil as a potential treatment opportunity for Alzheimer’s disease
Photo by David Matos on Unsplash
Sounds interesting?
Make sure to check out the full article in the link below
Network medicine for disease module identification and drug repurposing with the NeDRex platform
A new paper has been published recently under the title of Network medicine for disease module identification and drug repurposing with the NeDRex platform.
Sounds interesting?
You can navigate to the full text via the link below
Network pharmacology: curing causal mechanisms instead of treating symptoms
A new paper has been published recently under the title of Network pharmacology: curing causal mechanisms instead of treating symptoms.
Photo by Roberto Sorin on Unsplash
Sounds interesting?
Make sure to check out the full article in the link below